Post SARS-CoV-2 Vaccination Effluvium

September 2022 in “ European Journal of Dermatology ”

Ngoc‐Nhi C. Luu, Ralph M. Trüeb

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on pmc.ncbi.nlm.nih.gov →

Discuss this study in the Community →

Research cited in this study

5 / 5 results

Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

39 citations , August 2021 in “JAAD International”

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

research Telogen Effluvium Associated with COVID-19 Infection

44 citations , January 2021 in “Dermatologic Therapy”

COVID-19 may cause hair loss due to infection stress or treatments.

research What Can Hair Tell Us About COVID-19?

27 citations , December 2020 in “Experimental Dermatology”

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

research Telogen Effluvium: A Sequela of COVID-19

58 citations , November 2020 in “International Journal of Dermatology”

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

research SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study

51 citations , November 2020 in “Journal of the European Academy of Dermatology and Venereology”

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.